New stent device aims to fix dangerous aortic bulge without major surgery

NCT ID NCT06710938

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study is testing a new stent graft system designed to treat thoracoabdominal aortic aneurysms, a dangerous bulge in the main artery that runs through the chest and belly. The device has special branches to keep blood flowing to vital organs. Researchers will enroll 11 people to see if the device can be safely placed and works as intended, with follow-up for a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
thoracoabdominal artery stent graft system (a device with branches for key arteries)
What this could lead to
If successful, this could offer a less invasive treatment option for a complex type of aortic aneurysm, potentially reducing the need for open surgery.
What could go wrong
This is a very small, early exploratory study with only 11 people. The device may fail to work as intended, and there are serious risks like stroke, paralysis, or death.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THORACOABDOMINAL AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic aneurysm Aortic Aneurysm, Thoracoabdominal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asklepios Klinik Nord Heidberg

    RECRUITING

    Hamburg, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.